NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Expleo Solutions Limited (NSE: EXPLEOSOL)
EXPLEOSOL Technical Analysis
5
As on 17th Mar 2025 EXPLEOSOL SHARE Price closed @ 847.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1266.66 & Strong Sell for SHORT-TERM with Stoploss of 1150.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EXPLEOSOLSHARE Price
Open | 842.10 | Change | Price | % |
High | 851.75 | 1 Day | 2.95 | 0.35 |
Low | 842.10 | 1 Week | -12.35 | -1.44 |
Close | 847.35 | 1 Month | -149.95 | -15.04 |
Volume | 38576 | 1 Year | -424.80 | -33.39 |
52 Week High 1740.25 | 52 Week Low 1162.20 |
NSE INDIA Most Active Stocks
IDEA | 6.94 | -0.14% |
GTLINFRA | 1.48 | -1.33% |
YESBANK | 16.11 | -0.49% |
SUZLON | 54.50 | -0.15% |
ZOMATO | 203.69 | 1.12% |
TATASTEEL | 151.81 | 0.62% |
JPPOWER | 13.07 | -2.83% |
IDFCFIRSTB | 52.89 | -1.10% |
HCC | 22.77 | 0.66% |
PCJEWELLER | 13.39 | -4.15% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
EXPLEOSOL Daily Charts |
EXPLEOSOL Intraday Charts |
Whats New @ Bazaartrend |
EXPLEOSOL Free Analysis |
|
EXPLEOSOL Important Levels Intraday
RESISTANCE | 865.95 |
RESISTANCE | 859.98 |
RESISTANCE | 856.30 |
RESISTANCE | 852.61 |
SUPPORT | 842.09 |
SUPPORT | 838.40 |
SUPPORT | 834.72 |
SUPPORT | 828.75 |
EXPLEOSOL Target March 2025
4th UP Target | 1737.76 |
3rd UP Target | 1571.05 |
2nd UP Target | 1468.01 |
1st UP Target | 1364.96 |
1st DOWN Target | 1070.94 |
2nd DOWN Target | 967.89 |
3rd DOWN Target | 864.85 |
4th DOWN Target | 698.14 |
EXPLEOSOL Weekly Target
4th UP Target | 952.31 |
3rd UP Target | 917.70 |
2nd UP Target | 896.31 |
1st UP Target | 874.92 |
1st DOWN Target | 813.88 |
2nd DOWN Target | 792.49 |
3rd DOWN Target | 771.10 |
4th DOWN Target | 736.49 |
EXPLEOSOL Target2025
4th UP Target | 2218.43 |
3rd UP Target | 1957.91 |
2nd UP Target | 1796.88 |
1st UP Target | 1635.84 |
1st DOWN Target | 1176.36 |
2nd DOWN Target | 1015.32 |
3rd DOWN Target | 854.29 |
4th DOWN Target | 593.77 |
Expleo Solutions Limited ( NSE INDIA Symbol : EXPLEOSOL )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
EXPLEOSOL Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is Below 20 | Over Sold | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 229.90 | |
10 Day Avg Volume | Traded 5.81 % More then 10 Day Average Volume |
EXPLEOSOL Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
EXPLEOSOL Address
![]() |
EXPLEOSOL Latest News
EXPLEOSOL Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service